Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-01-04
2011-01-04
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S005000, C435S007900, C530S300000, C436S820000
Reexamination Certificate
active
07863008
ABSTRACT:
The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
REFERENCES:
patent: 4415491 (1983-11-01), Vyas
patent: 4469787 (1984-09-01), Woods et al.
patent: 4591552 (1986-05-01), Neurath
patent: 4742157 (1988-05-01), Yamanaka et al.
patent: 4839277 (1989-06-01), Sugahara et al.
patent: 5106726 (1992-04-01), Wang
patent: 5302507 (1994-04-01), Chiba et al.
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5436126 (1995-07-01), Wang
patent: 6596476 (2003-07-01), Lesniewski et al.
patent: 318216 (1989-05-01), None
patent: 0363 025 (1989-09-01), None
patent: 0 377 303 (1989-12-01), None
patent: 0 388 232 (1990-03-01), None
patent: 0 442 394 (1991-08-01), None
Sällberg et al., “Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site,” Immunology Letters, vol. 33 No. 1, pp. 27-33 (Jun. 1992).
U.S. Appl. No. 07/355,002, Houghton, not published.
U.S. Appl. No. 07/504,352, Houghton, not published.
Prince, et al, “Long-Incubation of Post-Transfusion Hepatitis Without Serological Evidence of Exposure to Hepatitis-B Virus”, The Lancet, 2:241 (1974).
Wilkins, “Late seroconversion following HPV -77, DE5 rubella virus vaccine”, Am. J. Obstet., Gynecol., 121(7):998-1002 (1974).
Prince, et al, “Postransfusion Viral Hepatitis caused by an Agent or Agents Other than Hepatitis B Virus or Hepatitis A Virus. Impact on Efficiency of Present Screening Methods”, Transmissible Disease & Blood Transfusion, Tibor et. al. eds., Grune & Stratton, Inc., pp. 129-140 (1975).
Prince, et al, “Non-A, Non-B Hepatitis: Reproduction of Disease in Chimpanzees and Identification of Virus Specific Antigen and Antibody”, Transplantation and Clinical Immunology, vol. X, Touraine et al. eds., Excerpta Medica, Amsterdam, pp. 8-17 (1979).
Houghten, et al,“Human Beta-Endorphin: Synthesis and Characterization of Analogs Iodinated and Tritated At Tyrosine Residues 1 and 27”, Int. K. Prot. Res., 16:311-320 (1980).
Prince, “Nature of Non-A, Non-B Hepatitis Viruses”, The Lancet, pp. 1181-2, (May 22, 1982).
Sutcliffe, et al, “Antibodies That React with Predetermined Sites on Proteins”, Science, 219(4585):600-666 (1983).
Prince, et al, “Use of Liver Cell Cultures in Studies on the Replication of Hepadna and Non-A, Non-B Viruses”, Viral Hepatitis and Liver Disease, Grune & Stratton, pp. 459-464 (1984).
Brotman, et al, “Non-A, Non-B Hepatitis: Is There More Than a Single Blood-Borne Strain?”, J. Infect. Diseases, 151( 4):618-625 (1985).
Gerber, et al, “Biology of Disease: Molecular and Cellular Pathology of Hepatitis B”, Laboratory Investigation, 52(6):572-590 (1985).
Allain, et al, “Seriological Markers in Early Stages of Human Immunodeficiency Virus Infection in Haemophiliacs”, The Lancet, pp. 1233-1236 (Nov. 29, 1986).
Brinton, et al, “Sequence and Secondary Structure Analysis of the 5′- Terminal Region of Flavivirus Genome RNA”, Virol., 162:290-299 (1988).
Collett, et al, “Molecular Cloning and Nucleotide Sequence of the Pestivirus Bovine Viral Diarrhea Virus”, Virol. 165:191-199 (1988).
Hahn, et al, “Nucleotide Sequence of Dengue 2 RNA and Comparison of the Encoded Proteins with Those of Other Flaviviruses”, Virol., 162:167-180 (1988).
Smith, et al, “Single-step purification of polypeptides expressed inEscherichia colias fusions with glutathione S-transferase”, Gene, 67:31-40 (1988).
Alter, et al, “Hepatitis C: And Miles to Go before We Sleep”, NEJM, 321:1538-39 (1989).
Choo, et al, “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome”, Science, 244:359-362 (1989).
Farzadegan, et al, “Performance of Serological Assays for Early Detection of Human Immunodeficiency Virus Type I Seroconversion”, J. of Clin. Microbio., 27(8):1882-1884 (1989).
Kuo, et al, “An Assay for Circulating Antibodies to a Major Etiologic Virus of Non-A, Non-B Hepatitis”, Science, 244:362-364 (1989).
Meyers, et al, “Molecular Cloning and Nucleotide Sequence of the Genome of Hog Cholera Virus”, Virol., 171:555-567 (1989).
Russell, et al, “Antibody-Antigen Binding In Organic Solvents”, Biochemical and Biophysical Research Communications, 158(1):80-85 (1989).
Alter, et al, “Detection of Antibody to Hepatitis C in Prospectively Followed Transfusion Recipients With Acute and Chronic Non-A, Non-B Hepatitis”, New Eng. J. of Med., 321(22):1494-1500 (1990).
Choo, et al, “Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis”, Br. Med. Bull., 46(2):423-441 (1990).
Gray, et al, “Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease”, Lancet, 335:609-610 (1990).
Kato, et al, “Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis”, PNAS, 87:9524-9528 (1990).
Maeno, et al, “A cDNA clone closely associated with non-A, non-B hepatitis”, Nucleic Acids Res., 18(9):2685-2689 (1990).
McFarlane, et al, “Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or false-positive result?”, Lancet, 335:754-757 (1990).
Miller, et al, “Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups”, PNAS, 87:2057-2061 (1990).
Okamoto, et al, “The 5′-Terminal Sequence of the Hepatitis C Virus Genome”, Jap. J. Exp. Med., 60(9):167-177 (1990).
Takeuchi, K, et al, “The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers”, J. of Gen. Virology, 71:3027-3033 (1990).
Takeuchi, et al, “Nucelotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human heathy carriers”, Nucl. Acids. Res., 18:4626 (1990).
Takeuchi, et al, “Hepatitis C viral cDNA clones isolated from a health carrier donor implicated in post-transfusion non-A, non-B hepatitis”, Gene, 91:287-291 (1990).
Weiner, et al, “Dectection of hepatitis C viral sequences in non-A, non-B hepatitis”, Lancet, 335:1-3 (1990).
Weiner, A.J., et al, “Variable and Hypervariable Domains Are Found in the Regions of HCV Corresponding to the Flavivirus Envelope and NS1 Proteins and the Pestivirus Envelope Glycoproteins”, Virology, 180:842-848 (1991, accepted for publication Oct. 18, 1990).
Prince, et al, “Non-A/Non-B Hepatitis: Identification of a Virus-specific Antigen and Antibody. A Preliminary Report”,Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention, Proceedings of the Second Symposium on Viral Hepatitis, Vyas, et al, eds., University of California, San Francisco, The Franklin Institute Press, Philadelphia, PA, Mar. 16-19, 1978, pp. 633-401.
Young, et al. “Efficient isolation of genes by using antibody probes”, Proc. Natl. Acad. Sci. USA, 80:1194-1198 (Mar. 1983).
Inchauspe Genevieve
Nasoff Marc S.
Prince Alfred M
Zebedee Suzanne
Bioprocess Pty Ltd.
Horning Michelle
Lucas Zachariah
Mueth Joseph E.
P. Hoffmann-La Roche, Ltd.
LandOfFree
Method for detecting NANBV associated seroconversion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting NANBV associated seroconversion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting NANBV associated seroconversion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643236